Bonde TM, Garmo H, Stattin P, Nilsson P, Gunnlaugsson A, Swanberg D, et al. Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists. AO [Internet]. 2023 Dec. 2 [cited 2024 Nov. 28];62(12):1815-21. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/35210